#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute on chronic liver failure Ichthyosis Neurofibromatosis Hepatitis D Lip and/or oral cavity cancer Lung adenocarcinoma Glomerulonephritis Sarcoidosis Hypomagnesaemia Non-small cell lung cancer metastatic Human papilloma virus immunisation B-cell lymphoma refractory Splenic marginal zone lymphoma Antiphospholipid syndrome Renal disorder More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Life with Disease Retinitis pigmentosa Glomerulonephritis membranoproliferative Nephrotic syndrome – Treatment Small intestine leiomyosarcoma – Trials in Disease Rhabdomyosarcoma Factor VIII deficiency – Diagnostics Testicular leiomyosarcoma – Basic Information Leiomyosarcoma metastatic – Treatment Combined immunodeficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ORG-129 Divarasib Deoxyribonucleic Acid Resamirigene Bilparvovec Levodopa Exemestane Antithrombin Iii Human Gsk3965193B Piperacillin Monohydrate Histamine Hydrochloride Oleclumab LY4170156 Altizide Macitentan Crisantaspase 12 Grass Pollen Mixture Phenobarbital Clebopride Hydrogen Maleate Carmustine Etamsylate More therapies…

    Learn about Your Condition

    Endometrial cancer Bladder cancer stage III Adenosquamous cell lung cancer Chronic sinusitis Perinatal depression Primary biliary cholangitis Acute leukaemia Cervix carcinoma stage I Mantle cell lymphoma stage III Splenic marginal zone lymphoma Peripheral spondyloarthritis Cervical dysplasia Endometrial cancer metastatic Anaplastic thyroid cancer Fallopian tube cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of 177Lu-PSMA and Stereotactic Radiotherapy vs. Radiotherapy for Patients with Oligometastatic Prostate Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • 177LU-PSMA-I&T
    Italy

  • Studying the Effects of Deferiprone on Motor Function in Children with Pelizaeus-Merzbacher Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pelizaeus-Merzbacher disease
    Investigated Drugs:
    • Deferiprone
    The Netherlands

  • Study on Dapansutrile for Patients with Type 2 Diabetes Not Well Controlled on Standard Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapansutrile
    Belgium France Germany

  • Study on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    Investigated Drugs:
    • Vaborbactam
    • Meropenem
    Czechia France Italy Poland Spain

  • Study of oxytocin, dinoprostone, and misoprostol combination for active management in pregnant women with premature rupture of membranes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Preterm premature rupture of membranes
    Investigated Drugs:
    • Dinoprostone
    • Mifepristone
    Italy

  • Study on the Safety of Repeated Intra-Arterial Infusion of Mesenchymal Stem Cells for Children and Adolescents with Refractory Epilepsy

    Recruiting

    1 1 1
    Investigated Diseases:
    • Rasmussen encephalitis
    Investigated Drugs:
    • Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Transduced With Icovir-5, Ex Vivo Expanded
    Spain
Previous Page
1 … 289 290 291 292 293 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!